INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LifeMD, Inc. - LFMD

Core Viewpoint - LifeMD, Inc. is under investigation for potential securities fraud and unlawful business practices following disappointing financial results and increased customer acquisition costs [1][3]. Financial Performance - On August 5, 2025, LifeMD reported its second quarter 2025 results, indicating that customer acquisition costs rose by 5% to 25% compared to the previous quarter, impacting the business negatively [3]. - The company's transition into the weight management space was highlighted as a significant factor in the increased costs, with analysts suggesting that management lost focus on customer acquisition for its RexMD platform [3]. Stock Market Reaction - Following the announcement of the second quarter results, LifeMD's stock price experienced a significant decline, falling by $5.31 per share, or 44.84%, closing at $6.53 per share on August 6, 2025 [4].